The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation
- 19 April 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 48 (5) , 1029-1031
- https://doi.org/10.1007/s00125-005-1731-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Activating Mutations in the KCNJ11 Gene Encoding the ATP-Sensitive K+ Channel Subunit Kir6.2 Are Rare in Clinically Defined Type 1 Diabetes Diagnosed Before 2 YearsDiabetes, 2004
- Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2Diabetes, 2004
- Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal DiabetesNew England Journal of Medicine, 2004
- Neonatal and very-early-onset diabetes mellitusSeminars in Neonatology, 2004
- Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 DiabetesDiabetes, 2003
- Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneityDiabetic Medicine, 1998
- Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDMDiabetes Care, 1994